Anti-hepatoma effect of arsenic trioxide on experimental liver cancer induced by 2-acetamidofluorene in rats

World Journal of Gastroenterology

Volumn 11, Issue 38, 2005, Pages 5938-5943

  Tan, Bing ^a   Huang, Jie Fei ^a   Wei, Qun ^a   Zhang, Hong ^a   Ni, Run Zhou ^a  

^a NANTONG MEDICAL COLLEGE   (China)

Author keywords

Arsenic trioxide; Cell proliferation; Liver cancer

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; MATRINE; N (2 FLUORENYL)ACETAMIDE; SODIUM CHLORIDE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MECHANISM; IMMUNOHISTOCHEMISTRY; LIVER CANCER; NONHUMAN; RAT; TREATMENT OUTCOME;

EID: 28644435021     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i38.5938     Document Type: Article

References (15)

1. Lee JH, Ku JL, Park YJ, Lee KU, Kim WH, Park JG. Establishment and characterization of four human hepatocellular carcinoma cell lines containing hepatitis B virus DNA. World J Gastroenterol 1999; 5: 289-295
2. Manesis EK, Giannoulis G, Zoumpoulis P, Vafiadou I, Hadziyannis SJ. Treatment of hepatocellular carcinoma with combined suppression and inhibition of sex hormones: a randomized controlled trial. Hepatology 1995; 21: 1535-1542
3. Chao Y, Chan WK, Huang YS, Teng HC, Wang SS, Lui WY, Whang-Peng J, Lee SD. Phase II study of flutamide in the treatment of hepatocellular carcinoma. Cancer 1996; 77: 635-639
4. Ram AM, Bhattacharya S, Novell JR, Dick R, Winslet MC, Hobbs KEF. Intra-arterial radiotherapy with 131 iodinelipiodol for irresectable hepatocellular carcinoma. Gut 1996; 38 (Suppl 1): A17
5. Dia J, Weinberg RS, Waxman S, Jing Y. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 1999; 93: 268-277
6. Zhang C, Wang SS, Qi QH. The morphplogical and cellular dynamic changes in Arsenic Trioxide-treated rat liver cancer. Zhongliu 2001; 21: 101-105
7. 2 cell line. Disan Junyi Daxue Xueba 2000; 22: 451
8. Wang Y, Yang SQ, Wang ZG, Tang S, Sun WG, Liu GZ. Expressive meaning of ras p21, C-erbB-2 and P16 protein in Hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 1999; 7: 808-809
9. Shen ZY, Shen J, Cai WJ. The alteration of mitochondria is an early event of arsenic trioxide induced apoptosis in esophageal carcinoma cells. Int J Mol Med 2000; 5: 155
10. Liu LX, Jiang HC, Zhuan AL, Zhou J, Wang XQ, Wu W. Arsenic trioxide induces apoptosis in hepatocellular carcinoma cells and to elucidate the possible mechanism. Zhonghua Yixue Zazhi 2001; 18: 1526-1527
11. Chen GQ, Zhu J, Shi XG, Ni GH, Zhong HJ, Si GY, Jin XL, Tang W, Li XS, Xong SM, Shen ZC, Sun GL, Ma J, Zhang P, Zhang TD, Gazin C, Naoe T, Chen SJ, Wang ZY, Chen Z. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3)in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood 1996; 88: 1052-1061
12. Liu TF, Cheng BL, Guan YG, Liang T. Study on relationship between expressions of CD44 and inhibition effect of arsenic trioxide on carcinoma. Haerbing Yikedaxue Xuebao 2001; 35: 111-112
13. 22 hepatocarcinoma rats. Zhonghua Weishengwuxue He Mianyixue Zazhi 2001; 21: 63
14. Kong HL, Crystal RG. Gene therapy strategies for tumor antiangiogenesis. J Natl Cancer Inst 1998; 90: 273-286
15. Ng IO, Poon RT, Lee JM, Fan ST, Ng M, Tso WK. Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma. Am J Clin Pathol 2001; 116: 838-845